Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide

Netherlands Journal of Medicine

Volumn 53, Issue 3, 1998, Pages 118-123

  Van De Loosdrecht, Arjan A ^a,b   Van Bodegraven, Ad A ^a,c   Sepers, Jan M ^a   Sindram, Jan W ^a,d  

^a Location Alkmaar   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Sophia Hospital   (Netherlands)

Author keywords

Neuroendocrine neoplasia; Octreotide; Paraprotein; Parathyroid hormone related protein

Indexed keywords

ALPHA2B INTERFERON; AMINOPROPANEDIPHOSPHONIC ACID; OCTREOTIDE; PARATHYROID HORMONE RELATED PROTEIN; PREDNISONE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERCALCEMIA; LIVER BIOPSY; METASTASIS; NEUROENDOCRINE TUMOR; PARAPROTEINEMIA;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; LYMPHATIC METASTASIS; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; PARAPROTEINEMIAS; TREATMENT OUTCOME;

EID: 0032169595     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(98)00075-8     Document Type: Article

References (29)

1. Fiasse R, Pauwels S, Rahier Jet al. Use of octreotide in the treatment of digestive neuroendocrine tumors. Seven year experience in 20 cases including 9 cases of metastatic midgut carcinoids and 5 cases of metastatic gastrinomas. Acta Gastroenterol Belg. 56:1993;279-291.
2. Lamberts SWJ, Krenning EP, Reubi JC The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Reviews. 12:1991;450-482.
3. Gordon P, Comi RJ, Maton PN, Go VLW Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. NIH Conference. Ann Int Med. 110:1989;35-50.
4. Kvols LK, Moertel CG, O'Connel MJ, Schutt AJ, Rubin J, Hahn RG Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 315:1986;663-666.
5. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ Octreotidede. N Engl J Med. 334:1996;246-254.
6. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 323:1990;1246-1249.
7. Lamberts SWJ, Hofland LJ, Koetsveld PMet al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors. Consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab. 71:1990;566-574.
8. Wiedenmann B, Jensen RT, Mignon Met al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg. 22:1998;309-318.
9. Budmiger H, Bühler H, Häcki W, Stamm B, Streuli R, Ammann R Comparitive diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with somatostatinoma. Gastroenterology. 92:1987;800-804.
10. Eriksson B, Alm G, Lundqvist G, Wilander E, Öberg K, Karlsson A, Andersson T, Wide L, Treatment of malignant endocrine pancreatic tumors with human leucocyte interferon. Lancet 1986;2:1306-1307.
11. Eriksson B, Öberg K, Skogseid B Neuroendocrine pancreatic tumors. Acta Oncologica. 28:1989;373-377.
12. Sreedharan SP, Kodama KT, Peterson KE, Goetzl E Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem. 264:1989;949-952.
13. Vanhagen PM, Krenning EP, Reubi JCet al. Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol. 83:1993;75-79.
14. Mitlak BH, Hutchison JS, Kaufman SD, Nussbaum SR Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas. Horm Metab Res. 23:1991;344-346.
15. Miraliakbari BA, Asa SL, Boudreau SF Parathyroid hormone like peptide in pancreatic endocrine carcinoma and adenocarcinoma associated with hypercalcemia. Hum Pathol. 23:1992;884-887.
16. Ratcliffe WA, Bowden SJ, Dunne FPet al. Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemia. Clin Endocrinol. 40:1994;679-686.
17. Sughishita K, Tanno M, Kijima M Malignant hypercalcemia due to gastric endocrine cell carcinoma. Int Med. 34:1995;104-107.
18. Mao C, Carter P, Schaefer Pet al. Malignant islet cell tumor associated with hypercalcemia. Surgery. 117:1995;37-40.
19. Mantzoros CS, Suva LJ, Moses AC, Spark R Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour. Clin Endocrinol. 46:1997;373-375.
20. Heitz PU, Klöppel G, Polak JM, Staub JJ Ectopic hormone production by endocrine tumors. Localization of hormones at the cellular level by immunocytochemistry. Cancer. 48:1981;2029-2037.
21. Asa SL, Henderson J, Goltzman D, Drucker DJ Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab. 71:1990;1112-1118.
22. Philbrick WM, Wysolmerski JJ, Galbraith Set al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev. 76:1996;127-173.
23. Stewart AF, Broadus AE Clinical review 16: parathyroid hormone-related proteins: coming of age in the 1990s. J Clin Endocrinol Metab. 71:1990;1410-1414.
24. Broadus AE, Mangin M, Ikeda Ket al. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med. 319:1988;556-563.
25. Burtis WJ, Brady TG, Orloff JJet al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med. 322:1990;1106-1112.
26. Heath DA, Senior PV, Varley JM, Beck F Parathyroid-hormone-related protein in tumours associated with hypercalcaemia. Lancet. 335:1990;66-69.
27. 111I n-octreotide scintigraphy Clin Endocrinol. 39:1993;239-243.
28. Arnold R, Trautmann ME, Creutzfeld W, Benning R, Neuhaus C, Jürgensen R, Stein K, Schäfer H, Bruns C, Dennler HJ. Somatostatin analogue octreotide and inhibition of tumor growth in metastatic endocrine gastroenteropancreatic tumors. Gut 1996;38:430-438.
29. 1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment. Clin Endocrinol. 48:1998;303-309.